NexgenRxNEGXF 51 Dividend Yield % is 2.25% as of Jul. 03, 2026, which is 37% below its 10-year median of 3.57. GuruFocus rates NEGXF with a GF Score™ of 51/100 and a GF Value™ of $0.27 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 282 Healthcare Providers & Services companies, NexgenRx ranks worse than 52.48% on this metric.
As of today (2026-07-03), the Trailing Annual Dividend Yield of NexgenRx is 2.25%.
Warning Sign:
NexgenRx Inc stock Dividend Yield % is close to 2-year low.
The historical rank and industry rank for NexgenRx's Dividend Yield % or its related term are showing as below:
NEGXF'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.3 Med: 3.57 Max: 5
Current: 2.25
During the past 13 years, the highest Dividend Yield of NexgenRx was 5.00%. The lowest was 1.30%. And the median was 3.57%.
NEGXF's Dividend Yield % is ranked worse than 52.48% of 282
companies
in the Healthcare Providers & Services industry
Industry Median: 2.375
vs NEGXF: 2.25
During the past 12 months, NexgenRx's average Dividends Per Share Growth Rate was 50.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 14.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of NexgenRx was 14.50% per year. The lowest was 14.50% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for NexgenRx's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NEGXF vs VEEV, BTSG, TEM: Dividend Yield % Comparison
For the Health Information Services subindustry, NexgenRx's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NexgenRx Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NexgenRx's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where NexgenRx's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
NexgenRx Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CAD 0.005000
2026-04-24
2026-04-24
2026-04-28
Cash Dividend
semi-annually
CAD:USD 0.731261
CAD 0.005000
2025-12-17
2025-12-17
2025-12-19
Cash Dividend
semi-annually
CAD:USD 0.729288
CAD 0.005000
2025-08-25
2025-08-25
2025-08-29
Cash Dividend
semi-annually
CAD:USD 0.725505
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
NexgenRx's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.01093027
/
0.325
=
3.36 %
Current Share Price is $0.325. NexgenRx's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.01093027.
NexgenRx's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.00731261
/
0.325
=
2.25 %
Current Share Price is $0.325. NexgenRx's Dividends per Share for the forward twelve months is calculated as $0.003656305 * 2 = $0.00731261.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexgenRx (NEGXF) has a Dividend Yield % of 2.25% as of Jul. 03, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on NexgenRx and its competitors. This is 37% below median its historical median of 3.57. Over the past decade, NexgenRx's Dividend Yield % has ranged from 1.30 to 5.00. According to the industry distribution chart, NexgenRx ranks #148 out of 282 companies in the Healthcare Providers & Services industry, placing it in the top 52.5%.
Is NexgenRx's Dividend Yield % too high?
NexgenRx's current Dividend Yield % of 2.25% is 37% below median its 10-year median of 3.57. Over the past 10 years, this metric has ranged from a low of 1.30 to a high of 5.00. The Healthcare Providers & Services industry median Dividend Yield % is 2.38. NexgenRx's value of 2.25% is 5.3% below this industry median. Based on the distribution chart, NexgenRx ranks #148 out of 282 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NexgenRx has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NexgenRx's Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NexgenRx ranks #148 out of 282 companies for Dividend Yield %. This places NexgenRx in the lower half of its industry. The industry median Dividend Yield % is 2.38. NexgenRx's value of 2.25% is 5.3% below this benchmark. Historically, NexgenRx's own Dividend Yield % has ranged from 1.30 to 5.00 over the past decade. While the company's 10-year median is 3.57 vs. the industry median of 2.38, NexgenRx has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.38, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NexgenRx's current Dividend Yield % of 2.25% is 5.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on NexgenRx and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NexgenRx's current Dividend Yield % is 2.25%, which is 37% below median its own 10-year median of 3.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexgenRx stock overvalued right now?
Based on GuruFocus' analysis, NexgenRx (NEGXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $0.33 — trading 20.4% above its estimated fair value. The current Dividend Yield % is 2.25%, which is 37% below median its 10-year median of 3.57 and 5.3% below the Healthcare Providers & Services industry median of 2.38. NexgenRx's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For NexgenRx (NEGXF), the current Dividend Yield % is 2.25% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NexgenRx (NEGXF) Overvalued in 2026?
Based on GuruFocus' analysis, NexgenRx stock appears to be overvalued.
The current stock price of $0.33 is trading 20.4% above its estimated GF Value™ of $0.27.
GuruFocus considers NexgenRx to be Modestly Overvalued.
Key valuation signals for NEGXF:
Dividend Yield %: 2.25% (37% below median its 10-year median of 3.57)
GF Value™: $0.27 vs. price of $0.33 (20.4% above fair value)
Industry Position: 5.3% below the Healthcare Providers & Services median (#148 of 282)
No single metric tells the full story. See the NEGXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
51GF Score
Get the complete analysis for NEGXF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEGXF has been successfully added to your 
